期刊文献+

瘦素和多囊卵巢综合征(PCOS)伴非酒精性脂肪肝(NAFLD)相关性的临床观察 被引量:6

Clinical observation on correlation between serum leptin and the non-alcoholic fatty liver disease(NAFLD) in women with polycystic ovary syndrome(PCOS)
下载PDF
导出
摘要 目的通过对多囊卵巢综合征(polycystic ovary syndrome,PCOS)人群中伴非酒精性脂肪肝(non-acoholic fatty liver disease,NAFLD)的分析,探讨瘦素与PCOS伴NAFLD之间的关系。方法收集35例PCOS伴有NAFLD的患者为脂肪肝组,同期选择35例PCOS不伴NAFLD的患者为非脂肪肝组,健康女性志愿者20例为对照组。所有受试者进行相关问卷调查建立个人病例档案,测量身高(height,H)、体重(weight,W)、体重指数(body mass index,BMI)、腰围(waist circumference,WC)、臀围(hip circumference,HC)及腰臀比(wasit hip ratio,WHR);检测血清睾酮(testosterone,T)、泌乳素(prolactin,PRL)、卵泡刺激素(folliclestimulating hormone,FSH)、黄体生成素(luteinizing hormone,LH)、雌二醇(estradiol,E2)、瘦素、空腹血糖(fasting blood sugar,FBG)、空腹胰岛素(fasting insulin,FINS)、餐后2h血糖(2hpostprandial blood glucose,2hPBG)、稳态模型胰岛素抵抗指数(homeostatic model assessment for insulin resistance,HOMA-IR)、总胆固醇(total cholesterol,TC)、三酰甘油(triglyceride,TG)、高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C)、低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C)及丙氨酸转氨酶(alaninetransaminase,ALT)等指标。结果两组PCOS的瘦素、W、BMI、WHR、T、LH、LH/FSH、FINS、PBG、HOMA-IR、LDL-C各项指标均高于对照组(P<0.05),FSH显著低于对照组(P<0.05);而PCOS伴NAFLD的瘦素、W、BMI、WC、HC、WHR、FINS、PBG、HOMA-IR、TG、LDL-C、ALT较不伴NAFLD显著升高(P<0.05),HDL-C显著降低(P<0.05)。脂肪肝组的瘦素水平与年龄、W、BMI、WC、HC、WHR、FINS、HOMA-IR及TG呈均显著正相关性(P<0.01),与HDL-C呈显著负相关性(P<0.01),控制与体脂有关的如W、BMI、WC、HC、WHR,脂肪肝组的瘦素水平与HOMA-IR、TG仍有显著正相关性(P<0.01)。结论瘦素水平异常与PCOS伴NAFLD的形成密切相关,及早重视瘦素干预,对于防治PCOS伴NAFLD有重要意义。 Objective To determine whether leptin is associated with the non-alcoholic fatty liver disease(NAFLD) in women with polycystic ovary syndrome(PCOS).Methods Seventy female PCOS patients of reproductive age(20-40 years) were recruited.Among them,35 patients were complicated with NAFLD(PCOS-NAFLD group) and the other were not complicated with NAFLD(PCOS-nNAFLD group).At the same time,20 healthy women volunteers(control group) were chosen as compared group.All subjects underwent relevant questionnaire and clinical exam.The clinical data,in terms of height(H),weight(W),body mass index(BMI),waist circumference(WC),hip circumference(HC),wasit hip ratio(WHR),testosterone(T),prolactin(PRL),follicle stimulating hormone(FSH),luteinizing hormone(LH),estradiol(E2),leptin,fasting blood sugar(FBG),fasting insulin(FINS),2 h postprandial blood glucose(2hPBG),homeostatic model assessment for insulin resistance(HOMA-IR),total cholesterol(TC),triglyceride(TG),low-density lipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C) and alanine transaminase(ALT) were collected,compared and analyzed.Results The levels of Leptin,weight,BMI,WHR,T,LH,LH/FSH,FINS,PBG,HOMA-IR,LDL-C in PCOS with or without NAFLD patients were significantly higer than those in control group(P0.05).The level of FSH in PCOS with or without NAFLD patients was lower than that in control group(P0.05).Furthermore,the levels of cholesterol and triglyceride were significantly higher in PCOS with NAFLD than in control group(P0.05).HDL-C was significantly lower in PCOS with NAFLD than in control group(P0.05).Compared with PCOS without NAFLD,the levels of leptin,FINS,PBG,HOMA-IR,TG,LDL-C,ALT were significantly higher in PCOS with NAFLD(P0.05).In addition,the level of HDL were significantly lower(P0.05).The occurrence of leptin was highly positively correlated with levels of age,weight,BMI,WC,HC,WHR,FINS,HOMA-IR,TG and highly negatively correlated with level of HDL-C(P0.01) in PCOS with NAFLD.After adjusting the factors of body fat such as W,BMI,WC,HC and WHR,the occurrence of leptin was still highly positively correlated with levels of HOMA-IR and TG(P0.01) in PCOS with NAFLD.Conclusions It is indicated that the disorder of leptin is closely related to the formation of PCOS with NAFLD.So,early treatment on leptin is of important significance for preventing PCOS with NAFLD.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2013年第2期211-216,共6页 Fudan University Journal of Medical Sciences
关键词 多囊卵巢综合征(PCOS) 非酒精性脂肪肝(NAFLD) 瘦素 高瘦素血症 瘦素抵抗 胰岛素抵抗(IR) polycystic ovary syndrome(PCOS) non-alcoholic fatty liver(NAFLD) leptin hyperleptinemia leptin resistance insulin resistance(IR)
  • 相关文献

参考文献26

  • 1Setji TL, Holland ND, Sanders LL, et al. Nonalcoholicsteatohepatitis and nonalcoholic fatty liver disease inyoung women with polycystic ovary syndrome[J]. J ClinEndocrinol Metab ,2006 ,91 (5) : 1741 — 1747.
  • 2陈晖,张真稳,朱妍,沈捷,马向华.伴或不伴非酒精性脂肪肝对多囊卵巢综合征患者代谢指标的影响[J].南京医科大学学报(自然科学版),2010,30(11):1629-1632. 被引量:5
  • 3Cerda C,Perez-Ayuso RM,Riquelme A,et al.Nonalcoholic fatty liver disease in women with polycysticovary syndrome [J]. J Hepatol ,2007,47(3) :412 - 417.
  • 4Gambarin-Gelwan M,Kinkhabwala SV,Schiano TD, etal. Prevalence of nonalcoholic fatty liver disease in womenwith polycystic ovary syndrome [ J]. Clin GastroenterolHepatol ,2007,5(4) :496 - 501.
  • 5Yildizhan R,Ilhan GA, Yildizhan B, et al. Serum retinol-binding protein 4,leptin, and plasma asymmetricdimethylarginine levels in obese and nonobese youngwomen with polycystic ovary syndrome [J]. Fertil Steril,2011,96(1):246- 250.
  • 6Golbahar J,Das NM, Al-Ayadhi MA, et al. Leptin-to-adiponectin, adiponectin-to-leptin ratios,and insulin arespecific and sensitive markers associated with polycysticovary syndrome: A case-control study from bahrain[J3.Metab Syndr Relat Disord ,2012,10(2) :98 - 102.
  • 7Rotterdam ESHRE/ ASRM-sponsored PCOS consensusworkshop group. Revised 2003 consensus on diagnosticcriteria and longterm health risks related to polycysticovary syndrome(PCOS) [J]. Fertil Steril,2004,81(1) :19-25.
  • 8Zeng MD, Fan JG,Lu LG, et al. Guidelines for thediagnosis and treatment of nonalcoholic fatty liver diseases[J]. J Dig 2008,9(2) : 108 ~ 112.
  • 9中华人民共和国卫生部制定.中药新药临床研究指导原则[M].北京:人民卫生出版社,1993:236.
  • 10Zhang Y?Proenca R,Maffei M,et aL Positional cloning ofthe mouse obese gene and its human homologue [ J].Nature,1994,372(6505) :425 _ 432.

二级参考文献17

  • 1黄卫娟,刘嘉茵.多囊卵巢综合征影响因素分析[J].江苏医药,2007,33(4):333-335. 被引量:5
  • 2Gambarin-Gelwan M,Kinkhabwala SV,Schiano TD, et al. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome[J]. Clin Gastroenterol He- patol,2007,5(4) :496-501.
  • 3Diamanti-Kandarakis E,Papavassiliou AG.Molecular mech- anisms of insulin resistance in polycystic ovary syndrome [J].Trends Mol Med,2006,12(7) :324-332.
  • 4Atamer A, Demir B, Bayhan G,et al.Serum levels of lep- tin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters [ J ].J Int Med Res, 2008,36 ( 1 ) : 96 -105.
  • 5Nemec ZM,Preininger K,English R,et al.Acute effect of leptin on hepatic glycogenolysis and gluconeogenesis in perfused rat liver[J ].Hepatology, 1999,29( 1 ) : 166-172.
  • 6Nesder JE, Jakubowicz DJ,de Vargas AF, et al.Insulin stinmlates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system[J]. J Clin Endocrinol Metab, 1998 , 83(6) :2001-2005.
  • 7Jakimiuk AJ,Weitsman SR, N avab A,et a l.Luteinizing hor- mone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries [J]J Clin Endocrinol Metab,2001,86 (3) : 1318- 1323.
  • 8Guzick DS.Polycystic ovary syndrome [J].Obstet Gynecol, 2004,103(1) : 181-193.
  • 9Seckl JR,Walker BR. 11beta-hydroxysteroid dehydroge- nase type 1 as a modulator of glucocorticoid action: from metabolism to memory [J]. Trends Endocrinol Metab, 2004, 15(9) :418-424.
  • 10Tsilchorozidou T, Honour JW, Conway GS. Altered corti- sol metabolism in polycystic ovary syndrome: insulin en- hances 5alpha-reduction but not the elevated adrenal steroid production rates[J].J Clin Endocrinol Metab,2003, 88(12) :5907-5913.

共引文献5

同被引文献71

  • 1张富青,邹芳,崔豫琳,李美芝.二甲双胍治疗肥胖型多囊卵巢综合征38例疗效观察[J].中国误诊学杂志,2004,4(6):894-895. 被引量:2
  • 2李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量:136
  • 3陈子江.高度重视多囊卵巢综合征的规范化诊断与治疗[J].中华妇产科杂志,2007,42(5):289-290. 被引量:69
  • 4洪鸣鸣,张月芳,冷建杭,陈瑾,王立建.瘦素与高脂血症痰浊证及脏腑相关性研究[J].中国中医药科技,2007,14(3):147-148. 被引量:4
  • 5曹泽毅.中华妇产科学(下册)[M].2版.北京:人民卫生出版社,2004:2437.
  • 6Setji TL, Holland ND, Sanders LL, et al. Nonalco- holic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2006, 91 (5) : 1741 -1747.
  • 7Faloia E, Canibus P, Gatti C, et al. Body compo- sition, fat distribution and metabolic characteris- tics in lean and obese women with polycystic ova- ry syndrome[ J ]. J Endocrinol Invest, 2004, 27 (5) : 424 -429.
  • 8Cerda C, Perez-Ayuso RM, Riquelme A, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome[J]. J Hepatol, 2007, 47(3) : 412 -417.
  • 9Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, et al. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syn- drome[ J ]. Clin Gastroenterol Hepatol, 2007, 5 (4) : 496 -500.
  • 10Rotterdam ESHRE/ASRM-Sponsored PCOS Con- sensus Workshop Group. Revised 2003 consen- sus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Fertil Steril, 2004, 81 (1) : 19 - 25.

引证文献6

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部